Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire
- PMID: 19622510
- DOI: 10.1093/annonc/mdp287
Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire
Abstract
Background: Monitoring adverse events during chemotherapy by clinicians is a standard practice but clinicians may report fewer side-effects or lower symptom severity than patients. Our aim was to compare symptoms self-reported by patients with symptoms registered by clinicians and nurses, to assess validity of a nurse reporting.
Methods: From April to August 2007, a double-blind questionnaire with 13 common items graduated according to the National Cancer Institute's Common Terminology Criteria for Adverse Events was completed by clinicians and nurses for outpatients undergoing chemotherapy at our Medical Oncology Day Hospital Unit. Patients completed a modified questionnaire with simplified terms. They were requested to specify seriousness of symptoms with a subjective scale varying from 1 to 4. Every patient-nurse-clinician questionnaire was registered for the statistical analysis. Agreement was evaluated by Cohen's kappa coefficient.
Results: Eighty-five paired questionnaires were completed. Patients, nurses and clinicians agreed on most symptoms and toxicity grade. Agreements between patients and nurses were stronger than those between patients and physicians for the six most common symptoms: asthenia (kappa 75% versus 37%), constipation (83% versus 45%), neuropathy (82% versus 55%), mucositis (78% versus 46%) and diarrhoea (90% versus 77%). These differences mainly reflected differences in the proportion of positive agreement: nurses were more able to detect symptoms self-reported by patients than physicians. The only exception was nausea, as kappa coefficient was very good for both health professionals (91% versus 89%). When considering the different grade of toxicity by the weighted kappa coefficient, we scored again the highest agreement between patient and nurse, with weighted kappa ranging from 55% (asthenia) to 86% (diarrhoea), and the lowest agreement between patient and physician, with weighted kappa ranging from 32% (asthenia) to 74% (nausea). The agreement between physician and nurse slightly improved, with weighted kappa ranging from 41% (constipation) to 77% (nausea).
Conclusion: Our results support the validity of nurse toxicity reporting and that the nurse staff could be successfully employed in collecting toxicity data because of a greater ability to elicit information from patients than the medical staff.
Comment in
-
Patient-reported outcomes in drug safety evaluation.Ann Oncol. 2009 Dec;20(12):1905-6. doi: 10.1093/annonc/mdp542. Ann Oncol. 2009. PMID: 19934250 No abstract available.
Similar articles
-
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study.Lancet Oncol. 2006 Nov;7(11):903-9. doi: 10.1016/S1470-2045(06)70910-X. Lancet Oncol. 2006. PMID: 17081915
-
Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer.JAMA Oncol. 2016 Apr;2(4):445-52. doi: 10.1001/jamaoncol.2015.4720. JAMA Oncol. 2016. PMID: 26720497
-
Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.Cancer. 2020 Jan 1;126(1):140-147. doi: 10.1002/cncr.32525. Epub 2019 Sep 25. Cancer. 2020. PMID: 31553494 Free PMC article.
-
Supporting quality and patient safety in cancer clinical trials.Clin J Oncol Nurs. 2011 Jun;15(3):263-5. doi: 10.1188/11.CJON.263-265. Clin J Oncol Nurs. 2011. PMID: 21624861 Review.
-
Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).Am Soc Clin Oncol Educ Book. 2016;35:67-73. doi: 10.1200/EDBK_159514. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249687 Review.
Cited by
-
A systematic review and meta-analysis of clinician-reported versus patient-reported outcomes of radiation dermatitis.Breast. 2020 Apr;50:125-134. doi: 10.1016/j.breast.2019.09.009. Epub 2019 Sep 19. Breast. 2020. PMID: 31563429 Free PMC article.
-
Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children.Support Care Cancer. 2014 Feb;22(2):359-66. doi: 10.1007/s00520-013-1981-6. Epub 2013 Sep 27. Support Care Cancer. 2014. PMID: 24072474
-
Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer.Oncologist. 2019 Dec;24(12):e1460-e1466. doi: 10.1634/theoncologist.2018-0882. Epub 2019 Jun 21. Oncologist. 2019. PMID: 31227648 Free PMC article.
-
Symptom management in women with recurrent ovarian cancer: Do patients and clinicians agree on what symptoms are most important?Gynecol Oncol. 2016 Nov;143(2):367-370. doi: 10.1016/j.ygyno.2016.08.235. Epub 2016 Aug 13. Gynecol Oncol. 2016. PMID: 27531571 Free PMC article.
-
Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials.J Natl Cancer Inst. 2021 Aug 2;113(8):980-988. doi: 10.1093/jnci/djab015. J Natl Cancer Inst. 2021. PMID: 33616650 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous